Plans unveiled for £1bn pharma centre at King’s Cross

Merck Kings Cross 2

R&D due to start next year if given the green light

Pharmaceutical’s firm Merck has revealed plans to build a £1bn R&D centre in a central London site opposite King’s Cross station.

Plans for the 10-storey building, designed by AHMM, have gone out to consultation, with construction expected to start next year if given the go ahead by Camden council.

Already registered? Login here

To continue enjoying Building.co.uk, sign up for free guest access

Existing subscriber? LOGIN

 

Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.

  • Limited access to building.co.uk
  • Breaking industry news as it happens
  • Breaking, daily and weekly e-newsletters

Get your free guest access  SIGN UP TODAY

Gated access promo

Subscribe now for unlimited access

 

Subscribe to Building today and you will benefit from:

  • Unlimited access to all stories including expert analysis and comment from industry leaders
  • Our league tables, cost models and economics data
  • Our online archive of over 10,000 articles
  • Building magazine digital editions
  • Building magazine print editions
  • Printed/digital supplements

Subscribe now for unlimited access.

View our subscription options and join our community